2nd REsolution Consortium Meeting

08.07.2022

On 20 June 2022, the REsolution consortium held its second consortium meeting, which was the first one in person since the project started. The event took place at CeMM with 20 participants coming from different countries.

REsolution scientists summarized the data generated on the collection and annotation of human genetic variants for SLCs and associated phenotypes. They also re-aligned on the strategies to characterize selected variants and perform deep mutational scanning studies on SLCs involved in human diseases. Finally, they discussed the interpretation of variant effects based on structural and functional information and compared to predicted effects by Variant Effect Predictors.

 More News

Open Access
 

Read our new open access publication by Palle Helmke, Barbara Füzi (former group member) and Gerhard Ecker on improving the drug development process.

Project
 

InSilify DrugTox is amongst the seven projects that were granted by the Austrian Science Fund FWF to enable research on different possibilities to...

News
 

We warmly welcome Sharath to the Pharminfo group! His expertise includes AI-assisted drug discovery and cheminformatics. We look forward to working...